H.R. 5052 - OPEN Act
- Sponsor:
- Kevin McCarthy
- Summary:
- To direct the Attorney General and the Secretary of Health and Human Services to evaluate the effectiveness of grant programs that provide grants for the primary purpose of providing assistance in addressing problems pertaining to opioid abuse, and for other purposes. (by CRS)
- Status:
- The bill was voted on in the House on May 10, 2016
PASSED on May 10, 2016.
2/3 required to pass
voted YES: 410
voted NO: 1
23 voted present/not voting
OPEN Act
H.R. 5052 — 114th Congress (2015–2016)
- Summary
- To direct the Attorney General and the Secretary of Health and Human Services to evaluate the effectiveness of grant programs that provide grants for the primary purpose of providing assistance in addressing problems pertaining to opioid abuse, and for other purposes. (by CRS)
- Learn More
- At OpenCongress
- Title
- To direct the Attorney General and the Secretary of Health and Human Services to evaluate the effectiveness of grant programs that provide grants for the primary purpose of providing assistance in addressing problems pertaining to opioid abuse, and for other purposes.
- Other Titles
- OPEN Act
- Opioid Program Evaluation Act
- OPEN Act
- Opioid Program Evaluation Act
- OPEN Act
- Opioid Program Evaluation Act
- OPEN Act
- Sponsor
- Kevin McCarthy
- Co-Sponsors
- Subjects
- Crime and law enforcement
- Drug trafficking and controlled substances
- Drug, alcohol, tobacco use
- Government studies and investigations
- Health programs administration and funding
- Law enforcement administration and funding
- Performance measurement
- Related Bills
- Major Actions
Introduced 4/26/2016 Referred to Committee Passed House 5/10/2016 - Bill History
-
Chamber/Committee Motion Date Result currently selected House On Motion to Suspend the Rules and Pass, as Amended: H R 5052 Opioid Program Evaluation Act 5/10/2016 This bill PASSED the House 410 voted YES 1 voted NO 23 voted present/not votingAction Date Description Introduced 4/26/2016 4/26/2016 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. 4/26/2016 Introduced in House 4/27/2016 Committee Consideration and Mark-up Session Held. Put on a legislative calendar 4/27/2016 Ordered to be Reported by Voice Vote. 4/28/2016 Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations. 4/29/2016 Referred to the Subcommittee on Health. 5/06/2016 Reported by the Committee on Judiciary. H. Rept. 114-541, Part I. 5/06/2016 Committee on Energy and Commerce discharged. Put on a legislative calendar 5/06/2016 Placed on the Union Calendar, Calendar No. 417. 5/10/2016 Mr. Goodlatte moved to suspend the rules and pass the bill, as amended. 5/10/2016 Considered under suspension of the rules. 5/10/2016 DEBATE - The House proceeded with forty minutes of debate on H.R. 5052. 5/10/2016 At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed. 5/10/2016 Considered as unfinished business. 5/10/2016 Motion to reconsider laid on the table Agreed to without objection. currently selected House Vote on Passage 5/10/2016 On Motion to Suspend the Rules and Pass, as Amended: H R 5052 Opioid Program Evaluation Act 5/11/2016 Received in the Senate and Read twice and referred to the Committee on the Judiciary. Number Sponsor Date Offered Status
MapLight did not identify any interest groups that took a position on this vote.
You may be able to explore campaign contributions data if you add interest groups.
Contributions data source: OpenSecrets.org